Cadrenal Therapeutics, Inc. (CVKD)
NASDAQ: CVKD · Real-Time Price · USD
1.960
-0.050 (-2.49%)
Aug 3, 2026, 4:00 PM EDT - Market closed
Cadrenal Therapeutics Market Cap
Cadrenal Therapeutics has a market cap or net worth of $5.62 million as of August 3, 2026. Its market cap has decreased by -73.41% in one year.
Market Cap
5.62M
Enterprise Value
3.31M
1-Year Change
-73.41%
Ranking
Category
Stock Price
$1.96
ChartMarket Cap Chart
Since the IPO on January 20, 2023, Cadrenal Therapeutics's market cap has decreased from $58.17M to $5.62M, a decrease of -90.34%. That is a compound annual growth rate of -48.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 3, 2026 | 5.62M | -64.54% |
| Dec 31, 2025 | 15.85M | -38.62% |
| Dec 31, 2024 | 25.83M | 168.05% |
| Dec 29, 2023 | 9.64M | -83.44% |
| Jan 20, 2023 | 58.17M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CollPlant Biotechnologies | 6.01M |
| Enveric Biosciences | 5.89M |
| Addex Therapeutics | 5.88M |
| Processa Pharmaceuticals | 5.86M |
| AIM ImmunoTech | 5.83M |
| NuCana | 5.62M |
| Soligenix | 5.60M |
| BioAtla | 5.41M |